Upcoming Trade Shows Munich, Germany for Science

The biotech and life sciences industry are Munich’s big earners and contributors to the city’s thriving economy. For decades, the city has held a critical role in furthering Germany’s vision to dominate the science industry in the European Union. The city actively attracts new scientific talent, continuously pulls in investment, and generates groundbreaking research at an impressive pace. The Munich region is the site of 25% of the country's clinical studies. The broader life sciences industry in the city includes biotech firms, global pharmaceutical companies, contract research organizations (CROs), and an array of related enterprises. The sector’s growth trajectory is remarkable. Fueling this growth is the city’s world-class research environment. Munich is home to the Ludwig Maximilians Universität (LMU) and the Technical University of Munich (TUM), which are the primary source of new scientific talent, which is ready to enter the workforce upon graduation. On the research side, there are multiple institutions that push the envelope. The best examples here would be the Helmholtz Zentrum Munich, several Fraunhofer Institutes, and the Munich School of BioEngineering (MSB), all of which are instrumental in courting companies to open offices in the Munich Metropolitan Area. Why go anywhere else when you have the perfect infrastructure set in place that works for you. The city itself prioritizes the harmonious exchange between academia and business as more and more organizations pop up for exactly this purpose. BioM directly manages Munich’s biotech cluster, and plays a crucial role in creating events, enabling networking, and securing funding. Young companies benefit from Innovation and Start-Up Centres for Biotechnology (IZB) in Planegg-Martinsried and Freising-Weihenstephan. In addition, the TUM School of Life Sciences in Weihenstephan focuses on food and biotech innovation, while the Max Planck Institute for Biochemistry, established in 1973, laid the foundation for the city’s biotech expansion.